leadf
logo-loader
view4D pharma plc

4D Pharma says it is unaware of any reasons for recent share price fall

Shares in 4D Pharma closed down 30% on Tuesday but recovered some losses on Wednesday

1544614268_microbiome2.jpg
The pharmaceutical company also confirmed that all clinical study timelines continue to progress as expected

4D Pharma PLC (LON:DDDD) on Wednesday said it was not aware of any reason for the recent fall in its share price.

The pharmaceutical company also confirmed that all clinical study timelines continue to progress as expected.

READ: 4D Pharma bullish on progress of microbiome-based cancer research

4D Pharma notes the recent fall in its share price and confirms that it is not aware of any company related matter which could be responsible for this price movement. The board also confirms that all clinical study timelines continue to progress as expected,” the company said in a statement.

Shares in 4D Pharma closed down 30% on Tuesday but were 10% up at 98p in late morning trade on Wednesday.

Quick facts: 4D pharma plc

Price: 133.5 GBX

LSE:DDDD
Market: LSE
Market Cap: £175.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of 4D pharma plc named herein, including the promotion by the Company of 4D pharma plc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

4D pharma plc merges with SPAC company Longevity Acquisition Corp

4D pharma plc (LON:DDDD) CEO Duncan Peyton tells Proactive the group is to get a cash injection of US$14.6mln through a merger with Longevity Acquisition Corporation (NASDAQ:LOAC), a special purpose acquisition company. Peyton says the merger will accelerate and de-risk 4D's admission to...

2 days, 8 hours ago

2 min read